Medicare Beneficiaries Hoping GLP-1 Coverage for Weight Loss
A policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,404 articlesA policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
When a Veeco director sells a large block, it sparks questions. This article explains what insider trades mean, how t...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...
Micron Technology finished a powerful year in 2026, with profits surging as AI infrastructure needs grew. This guide ...
A quiet, disciplined bet on the entire U.S. equity landscape. Pennington Partners increasing its stake in VTHR highli...
Nike is flirting with a comeback narrative as it gears up for June earnings. This guide breaks down what to watch, ho...
Rivian has captured investor attention again as the stock trades under $20. This guide breaks down whether a $5,000 i...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
Nuclear energy is a long game for investors. This guide weighs NuScale Power against Oklo as a path to exposure in th...
A small stake in a leading solar company sparked big learning for investors. This million solar lands move shows how ...
Curious about what the Agilent 2026 earnings call means for investors? This article breaks down the key takeaways, po...